TreeWAS – Variant ID: rs630923

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Showing all nodes without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
C85 Other and unspecified types of non-Hodgkin's lymphoma	0.855	0.145	0.000
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.854	0.146	0.000
C83 Diffuse non-Hodgkin's lymphoma	0.849	0.151	0.000
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.847	0.153	0.000
C83.3 Large cell (diffuse)	0.839	0.161	0.000
C85.9 Non-Hodgkin's lymphoma, unspecified type	0.829	0.171	0.000
C85.1 B-cell lymphoma, unspecified	0.829	0.171	0.000
C82.9 Follicular non-Hodgkin's lymphoma, unspecified	0.822	0.178	0.000
C83.0 Small cell (diffuse)	0.769	0.231	0.000
C82.7 Other types of follicular non-Hodgkin's lymphoma	0.766	0.234	0.000
C92 Myeloid leukaemia	0.725	0.275	0.000
C82.2 Large cell, follicular	0.694	0.306	0.000
C85.2 Mediastinal (thymic) large B-cell lymphoma	0.690	0.310	0.000
C85.7 Other specified types of non-Hodgkin's lymphoma	0.669	0.331	0.000
C93 Monocytic leukaemia	0.639	0.361	0.000
C82.3 Follicular lymphoma grade IIIa	0.636	0.364	0.000
C81 Hodgkin's disease	0.631	0.369	0.000
C83.1 Small cleaved cell (diffuse)	0.619	0.381	0.000
C82.0 Small cleaved cell, follicular	0.613	0.387	0.000
C85.0 Lymphosarcoma	0.613	0.387	0.000
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.612	0.388	0.000
C94 Other leukaemias of specified cell type	0.612	0.388	0.000
C86 Other specified types of T/NK-cell lymphoma	0.612	0.388	0.000
C83.8 Other types of diffuse non-Hodgkin's lymphoma	0.611	0.389	0.000
C83.6 Undifferentiated (diffuse)	0.609	0.391	0.000
C83.5 Lymphoblastic (diffuse)	0.609	0.391	0.000
C83.4 Immunoblastic (diffuse)	0.609	0.391	0.000
C83.2 Mixed small and large cell (diffuse)	0.609	0.391	0.000
C82.6 Cutaneous follicle centre lymphoma	0.607	0.392	0.000
C82.5 Diffuse follicle centre lymphoma	0.607	0.392	0.000
C82.4 Follicular lymphoma grade IIIb	0.607	0.392	0.000
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified	0.606	0.394	0.000
C92.1 Chronic myeloid leukaemia	0.592	0.408	0.000
C82.1 Mixed small cleaved and large cell, follicular	0.591	0.409	0.000
C95 Leukaemia of unspecified cell type	0.588	0.412	0.000
C92.0 Acute myeloid leukaemia	0.579	0.420	0.000
C88 Malignant immunoproliferative diseases	0.571	0.429	0.000
C83.7 Burkitt's tumour	0.555	0.445	0.000
C92.9 Myeloid leukaemia, unspecified	0.550	0.450	0.000
C81.1 Nodular sclerosis	0.545	0.455	0.000
C92.8 Acute myeloid leukaemia with multilineage dysplasia	0.520	0.480	0.000
C92.7 Other myeloid leukaemia	0.520	0.480	0.000
C92.6 Acute myeloid leukaemia with 11q23-abnormality	0.520	0.480	0.000
C92.5 Acute myelomonocytic leukaemia	0.520	0.480	0.000
C92.3 Myeloid sarcoma	0.520	0.480	0.000
C92.2 Subacute myeloid leukaemia	0.520	0.480	0.000
C92.4 Acute promyelocytic leukaemia	0.494	0.506	0.000
C93.1 Chronic monocytic leukaemia	0.485	0.514	0.000
C93.9 Monocytic leukaemia, unspecified	0.458	0.542	0.000
C93.7 Other monocytic leukaemia	0.458	0.542	0.000
C93.3 Juvenile myelomonocytic leukaemia	0.458	0.542	0.000
C93.2 Subacute monocytic leukaemia	0.458	0.542	0.000
C93.0 Acute monocytic leukaemia	0.458	0.542	0.000
C81.7 Other Hodgkin's disease	0.452	0.548	0.000
C81.4 Lymphocyte-rich classical Hodgkin lymphoma	0.452	0.548	0.000
C81.3 Lymphocytic depletion	0.452	0.548	0.000
C81.2 Mixed cellularity	0.452	0.548	0.000
C86.6 Primary cutaneous CD30-positive T-cell proliferations	0.439	0.561	0.000
C86.5 Angioimmunoblastic T-cell lymphoma	0.439	0.561	0.000
C86.4 Blastic NK-cell lymphoma	0.439	0.561	0.000
C86.3 Subcutaneous panniculitis-like T-cell lymphoma	0.439	0.561	0.000
C86.2 Enteropathy-type (intestinal) T-cell lymphoma	0.439	0.561	0.000
C86.1 Hepatosplenic T-cell lymphoma	0.439	0.561	0.000
C86.0 Extranodal NK/T-cell lymphoma, nasal type	0.439	0.561	0.000
C94.7 Other specified leukaemias	0.439	0.561	0.000
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified	0.439	0.561	0.000
C94.5 Acute myelofibrosis	0.439	0.561	0.000
C94.4 Acute panmyelosis	0.439	0.561	0.000
C94.3 Mast cell leukaemia	0.439	0.561	0.000
C94.2 Acute megakaryoblastic leukaemia	0.439	0.561	0.000
C94.1 Chronic erythraemia	0.439	0.561	0.000
C94.0 Acute erythraemia and erythroleukaemia	0.439	0.561	0.000
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified	0.439	0.561	0.000
C96.8 Histiocytic sarcoma	0.439	0.561	0.000
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.439	0.561	0.000
C96.6 Unifocal Langerhans-cell histiocytosis	0.439	0.561	0.000
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis	0.439	0.561	0.000
C96.4 Sarcoma of dendritic cells (accessory cells)	0.439	0.561	0.000
C96.3 True histiocytic lymphoma	0.439	0.561	0.000
C96.2 Malignant mast cell tumour	0.439	0.561	0.000
C96.1 Malignant histiocytosis	0.439	0.561	0.000
C96.0 Letterer-Siwe disease	0.439	0.561	0.000
C81.0 Lymphocytic predominance	0.437	0.562	0.000
C84 Peripheral and cutaneous T-cell lymphomas	0.433	0.566	0.000
C95.7 Other leukaemia of unspecified cell type	0.422	0.578	0.000
C95.2 Subacute leukaemia of unspecified cell type	0.422	0.578	0.000
C95.1 Chronic leukaemia of unspecified cell type	0.422	0.578	0.000
C95.0 Acute leukaemia of unspecified cell type	0.422	0.578	0.000
C88.9 Malignant immunoproliferative disease, unspecified	0.409	0.591	0.000
C88.7 Other malignant immunoproliferative diseases	0.409	0.591	0.000
C88.3 Immunoproliferative small intestinal disease	0.409	0.591	0.000
C88.2 Gamma heavy chain disease	0.409	0.591	0.000
C88.1 Alpha heavy chain disease	0.409	0.591	0.000
C95.9 Leukaemia, unspecified	0.398	0.602	0.000
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]	0.395	0.605	0.000
C90 Multiple myeloma and malignant plasma cell neoplasms	0.388	0.612	0.000
C88.0 Waldenstrom's macroglobulinaemia	0.384	0.616	0.000
C91 Lymphoid leukaemia	0.349	0.651	0.000
C81.9 Hodgkin's disease, unspecified	0.322	0.678	0.000
C84.9 Mature T/NK-cell lymphoma, unspecified	0.311	0.689	0.000
C84.8 Cutaneous T-cell lymphoma, unspecified	0.311	0.689	0.000
C84.7 Anaplastic large cell lymphoma, ALK-negative	0.311	0.689	0.000
C84.6 Anaplastic large cell lymphoma, ALK-positive	0.311	0.689	0.000
C84.3 Lymphoepithelioid lymphoma	0.311	0.689	0.000
C84.2 T-zone lymphoma	0.311	0.689	0.000
C84.1 Sezary's diease	0.311	0.689	0.000
C84.0 Mycosis fungoides	0.311	0.689	0.000
C90.1 Plasma cell leukaemia	0.298	0.702	0.000
C90.3 Solitary plasmacytoma	0.278	0.722	0.000
C84.4 Peripheral T-cell lymphoma	0.255	0.744	0.001
C91.8 Mature B-cell leukaemia Burkitt-type	0.250	0.750	0.000
C91.7 Other lymphoid leukaemia	0.250	0.750	0.000
C91.6 Prolymphocytic leukaemia of T-cell type	0.250	0.750	0.000
C91.5 Adult T-cell leukaemia	0.250	0.750	0.000
C91.3 Prolymphocytic leukaemia	0.250	0.750	0.000
C91.2 Subacute lymphocytic leukaemia	0.250	0.750	0.000
C91.4 Hairy-cell leukaemia	0.235	0.765	0.000
C90.2 Plasmacytoma, extramedullary	0.234	0.765	0.000
C91.9 Lymphoid leukaemia, unspecified	0.228	0.771	0.000
C84.5 Other and unspecified T-cell lymphomas	0.226	0.774	0.001
C91.0 Acute lymphoblastic leukaemia	0.216	0.783	0.000
C91.1 Chronic lymphocytic leukaemia	0.157	0.843	0.000
C90.0 Multiple myeloma	0.097	0.902	0.000
C71.9 Brain, unspecified	0.000	0.959	0.041
C71 Malignant neoplasm of brain	0.000	0.961	0.039
C71.2 Temporal lobe	0.000	0.962	0.038
C71.3 Parietal lobe	0.000	0.968	0.032
C71.0 Cerebrum, except lobes and ventricles	0.000	0.968	0.032
C71.8 Overlapping lesion of brain	0.000	0.970	0.030
C71.1 Frontal lobe	0.000	0.971	0.029
C71.4 Occipital lobe	0.000	0.971	0.029
C71.7 Brain stem	0.000	0.972	0.028
C71.6 Cerebellum	0.000	0.972	0.028
C71.5 Cerebral ventricle	0.000	0.972	0.028
M75.4 Impingement syndrome of shoulder	0.000	0.981	0.019
T39.1 4-Aminophenol derivatives	0.000	0.982	0.018
T39.0 Salicylates	0.000	0.982	0.018
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.000	0.982	0.018
M75.1 Rotator cuff syndrome	0.000	0.983	0.017
M75.0 Adhesive capsulitis of shoulder	0.000	0.983	0.017
M75 Shoulder lesions	0.000	0.984	0.016
E80.4 Gilbert's syndrome	0.014	0.986	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.000	0.986	0.014
C69-C72 Malignant neoplasms of eye, brain and other parts of central nervous system	0.000	0.987	0.013
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.000	0.987	0.013
T39.4 Antirheumatics, not elsewhere classified	0.000	0.987	0.013
T39.2 Pyrazolone derivatives	0.000	0.987	0.013
N03.9 Unspecified	0.000	0.987	0.013
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.000	0.988	0.012
T45.0 Antiallergic and antiemetic drugs	0.000	0.988	0.012
T36-T50 Poisoning by drugs, medicaments and biological substances	0.000	0.988	0.012
S01.9 Open wound of head, part unspecified	0.000	0.988	0.012
M75.8 Other shoulder lesions	0.000	0.988	0.012
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.000	0.989	0.011
Z85.7 Personal history of other malignant neoplasms of lymphoid, haematopoietic and related tissues	0.011	0.989	0.000
M75.9 Shoulder lesion, unspecified	0.000	0.989	0.011
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.000	0.990	0.010
C72 Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system	0.000	0.990	0.010
C70 Malignant neoplasm of meninges	0.000	0.990	0.010
T45.5 Anticoagulants	0.000	0.990	0.010
T36 Poisoning by systemic antibiotics	0.000	0.990	0.010
T45.1 Antineoplastic and immunosuppressive drugs	0.000	0.990	0.010
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.000	0.990	0.010
N85.2 Hypertrophy of uterus	0.000	0.990	0.010
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.000	0.990	0.009
T46 Poisoning by agents primarily affecting the cardiovascular system	0.000	0.991	0.009
T40.6 Other and unspecified narcotics	0.000	0.991	0.009
T45.9 Primarily systemic and haematological agent, unspecified	0.000	0.991	0.009
T45.8 Other primarily systemic and haematological agents	0.000	0.991	0.009
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.000	0.991	0.009
T45.6 Fibrinolysis-affecting drugs	0.000	0.991	0.009
T45.4 Iron and its compounds	0.000	0.991	0.009
T45.3 Enzymes, not elsewhere classified	0.000	0.991	0.009
T45.2 Vitamins, not elsewhere classified	0.000	0.991	0.009
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.000	0.991	0.009
G35 Multiple sclerosis	0.000	0.991	0.009
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.000	0.991	0.009
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.000	0.991	0.009
T41 Poisoning by anaesthetics and therapeutic gases	0.000	0.991	0.009
M75.81 Other shoulder lesions, right shoulder	0.000	0.991	0.008
T40.2 Other opioids	0.000	0.991	0.009
M75.2 Bicipital tendinitis	0.000	0.991	0.009
M75.3 Calcific tendinitis of shoulder	0.000	0.991	0.009
C69 Malignant neoplasm of eye and adnexa	0.000	0.992	0.008
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.000	0.992	0.008
T36.0 Penicillins	0.000	0.992	0.008
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.992	0.008
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.000	0.992	0.008
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.000	0.992	0.007
T40.8 Lysergide [LSD]	0.000	0.992	0.007
T40.7 Cannabis (derivatives)	0.000	0.992	0.007
T40.5 Cocaine	0.000	0.992	0.007
T40.3 Methadone	0.000	0.992	0.007
T40.1 Heroin	0.000	0.992	0.007
T40.0 Opium	0.000	0.992	0.007
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.000	0.992	0.008
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.000	0.992	0.007
S01.1 Open wound of eyelid and periocular area	0.000	0.993	0.007
T46.4 Angiotensin-converting-enzyme inhibitors	0.000	0.993	0.007
C70.9 Meninges, unspecified	0.000	0.993	0.007
C70.1 Spinal meninges	0.000	0.993	0.007
C70.0 Cerebral meninges	0.000	0.993	0.007
C72.9 Central nervous system, unspecified	0.000	0.993	0.007
C72.8 Overlapping lesion of brain and other parts of central nervous system	0.000	0.993	0.007
C72.5 Other and unspecified cranial nerves	0.000	0.993	0.007
C72.4 Acoustic nerve	0.000	0.993	0.007
C72.3 Optic nerve	0.000	0.993	0.007
C72.2 Olfactory nerve	0.000	0.993	0.007
C72.1 Cauda equina	0.000	0.993	0.007
C72.0 Spinal cord	0.000	0.993	0.007
T36.9 Systemic antibiotic, unspecified	0.000	0.993	0.007
T36.8 Other systemic antibiotics	0.000	0.993	0.007
T36.7 Antifungal antibiotics, systemically used	0.000	0.993	0.007
T36.6 Rifamycins	0.000	0.993	0.007
T36.5 Aminoglycosides	0.000	0.993	0.007
T36.4 Tetracyclines	0.000	0.993	0.007
T36.3 Macrolides	0.000	0.993	0.007
T36.2 Chloramphenicol group	0.000	0.993	0.007
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.000	0.993	0.007
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.000	0.993	0.007
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.000	0.993	0.007
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.993	0.007
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.000	0.993	0.007
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.000	0.993	0.007
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.000	0.993	0.007
T44.1 Other parasympathomimetics [cholinergics]	0.000	0.993	0.007
T44.0 Anticholinesterase agents	0.000	0.993	0.007
E80 Disorders of porphyrin and bilirubin metabolism	0.007	0.993	0.000
S01.8 Open wound of other parts of head	0.000	0.993	0.007
T38.1 Thyroid hormones and substitutes	0.000	0.993	0.007
T38.9 Other and unspecified hormone antagonists	0.000	0.993	0.007
T38.8 Other and unspecified hormones and their synthetic substitutes	0.000	0.993	0.007
T38.7 Androgens and anabolic congeners	0.000	0.993	0.007
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.000	0.993	0.007
T38.5 Other oestrogens and progestogens	0.000	0.993	0.007
T38.4 Oral contraceptives	0.000	0.993	0.007
T38.2 Antithyroid drugs	0.000	0.993	0.007
T38.0 Glucocorticoids and synthetic analogues	0.000	0.993	0.007
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.000	0.993	0.007
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.000	0.993	0.007
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.000	0.993	0.007
T46.8 Antivaricose drugs, including sclerosing agents	0.000	0.993	0.007
T46.7 Peripheral vasodilators	0.000	0.993	0.007
T46.5 Other antihypertensive drugs, not elsewhere classified	0.000	0.993	0.007
T46.3 Coronary vasodilators, not elsewhere classified	0.000	0.993	0.007
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.000	0.993	0.007
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.000	0.993	0.007
T50.9 Other and unspecified drugs, medicaments and biological substances	0.000	0.993	0.007
T50.8 Diagnostic agents	0.000	0.993	0.007
T50.7 Analeptics and opioid receptor antagonists	0.000	0.993	0.007
T50.6 Antidotes and chelating agents, not elsewhere classified	0.000	0.993	0.007
T50.5 Appetite depressants	0.000	0.993	0.007
T50.4 Drugs affecting uric acid metabolism	0.000	0.993	0.007
T50.3 Electrolytic, caloric and water-balance agents	0.000	0.993	0.007
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.000	0.993	0.007
T50.1 Loop [high-ceiling] diuretics	0.000	0.993	0.007
T50.0 Mineralocorticoids and their antagonists	0.000	0.993	0.007
S01 Open wound of head	0.000	0.993	0.007
T41.5 Therapeutic gases	0.000	0.993	0.007
T41.4 Anaesthetic, unspecified	0.000	0.993	0.007
T41.3 Local anaesthetics	0.000	0.993	0.007
T41.2 Other and unspecified general anaesthetics	0.000	0.993	0.007
T41.1 Intravenous anaesthetics	0.000	0.993	0.007
T41.0 Inhaled anaesthetics	0.000	0.993	0.007
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.000	0.993	0.007
T48.6 Antiasthmatics, not elsewhere classified	0.000	0.993	0.007
T48.5 Anti-common-cold drugs	0.000	0.993	0.007
T48.4 Expectorants	0.000	0.993	0.007
T48.3 Antitussives	0.000	0.993	0.007
T48.2 Other and unspecified agents primarily acting on muscles	0.000	0.993	0.007
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.000	0.993	0.007
T48.0 Oxytocic drugs	0.000	0.993	0.007
T49.9 Topical agent, unspecified	0.000	0.993	0.007
T49.8 Other topical agents	0.000	0.993	0.007
T49.7 Dental drugs, topically applied	0.000	0.993	0.007
T49.6 Otorhinolaryngological drugs and preparations	0.000	0.993	0.007
T49.5 Ophthalmological drugs and preparations	0.000	0.993	0.007
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.000	0.993	0.007
T49.3 Emollients, demulcents and protectants	0.000	0.993	0.007
T49.2 Local astringents and local detergents	0.000	0.993	0.007
T49.1 Antipruritics	0.000	0.993	0.007
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.000	0.993	0.007
T46.1 Calcium-channel blockers	0.000	0.993	0.006
G37.9 Demyelinating disease of central nervous system, unspecified	0.000	0.993	0.007
S32.70 Multiple fractures of lumbar spine and pelvis (closed)	0.000	0.993	0.006
G35-G37 Demyelinating diseases of the central nervous system	0.000	0.994	0.006
G37 Other demyelinating diseases of central nervous system	0.000	0.994	0.006
T42.4 Benzodiazepines	0.000	0.994	0.006
C69.3 Choroid	0.000	0.994	0.006
T42.1 Iminostilbenes	0.000	0.994	0.006
C69.8 Overlapping lesion of eye and adnexa	0.000	0.994	0.006
C69.6 Orbit	0.000	0.994	0.006
C69.5 Lachrymal gland and duct	0.000	0.994	0.006
C69.4 Ciliary body	0.000	0.994	0.006
C69.2 Retina	0.000	0.994	0.006
C69.1 Cornea	0.000	0.994	0.006
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.000	0.994	0.006
T37.5 Antiviral drugs	0.000	0.994	0.006
T37.4 Anthelminthics	0.000	0.994	0.006
T37.3 Other antiprotozoal drugs	0.000	0.994	0.006
T37.2 Antimalarials and drugs acting on other blood protozoa	0.000	0.994	0.006
T37.1 Antimycobacterial drugs	0.000	0.994	0.006
T37.0 Sulphonamides	0.000	0.994	0.006
K60.3 Anal fistula	0.000	0.994	0.006
E80.6 Other disorders of bilirubin metabolism	0.006	0.994	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.000	0.994	0.006
T47.8 Other agents primarily affecting the gastro-intestinal system	0.000	0.994	0.006
T47.7 Emetics	0.000	0.994	0.006
T47.6 Antidiarrhoeal drugs	0.000	0.994	0.006
T47.5 Digestants	0.000	0.994	0.006
T47.4 Other laxatives	0.000	0.994	0.006
T47.3 Saline and osmotic laxatives	0.000	0.994	0.006
T47.0 Histamine H(2)-receptor antagonists	0.000	0.994	0.006
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.000	0.994	0.006
T42.5 Mixed antiepileptics, not elsewhere classified	0.000	0.994	0.006
T42.3 Barbiturates	0.000	0.994	0.006
T42.2 Succinimides and oxazolidinediones	0.000	0.994	0.006
N03 Chronic nephritic syndrome	0.000	0.994	0.006
T47.1 Other antacids and anti-gastric-secretion drugs	0.000	0.994	0.005
C69.9 Eye, unspecified	0.000	0.994	0.005
T42.0 Hydantoin derivatives	0.000	0.994	0.005
E80.7 Disorder of bilirubin metabolism, unspecified	0.005	0.995	0.000
E80.5 Crigler-Najjar syndrome	0.005	0.995	0.000
E80.3 Defects of catalase and peroxydase	0.005	0.995	0.000
E80.2 Other porphyria	0.005	0.995	0.000
E80.1 Porphyria cutanea tarda	0.005	0.995	0.000
E80.0 Hereditary erythropoietic porphyria	0.005	0.995	0.000
K26.9 Unspecified as acute or chronic, without haemorrhage or perforation	0.000	0.995	0.005
C69.0 Conjunctiva	0.000	0.995	0.005
T37.8 Other specified systemic anti-infectives and antiparasitics	0.000	0.995	0.005
L29.9 Pruritus, unspecified	0.005	0.995	0.000
G37.3 Acute transverse myelitis in demyelinating disease of central nervous system	0.000	0.995	0.005
T47.2 Stimulant laxatives	0.000	0.995	0.005
H81.1 Benign paroxysmal vertigo	0.005	0.995	0.000
G36 Other acute disseminated demyelination	0.000	0.995	0.005
G37.8 Other specified demyelinating diseases of central nervous system	0.000	0.995	0.005
G37.5 Concentric sclerosis [Balo]	0.000	0.995	0.005
G37.4 Subacute necrotising myelitis	0.000	0.995	0.005
G37.2 Central pontine myelinolysis	0.000	0.995	0.005
G37.1 Central demyelination of corpus callosum	0.000	0.995	0.005
G37.0 Diffuse sclerosis	0.000	0.995	0.005
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.000	0.995	0.005
S01.7 Multiple open wounds of head	0.000	0.995	0.005
S32.7 Multiple fractures of lumbar spine and pelvis	0.000	0.995	0.005
T40.4 Other synthetic narcotics	0.000	0.995	0.004
M75.5 Bursitis of shoulder	0.000	0.995	0.005
L29.0 Pruritus ani	0.005	0.995	0.000
S42.00 Fracture of clavicle (closed)	0.000	0.995	0.005
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.000	0.995	0.005
J33.0 Polyp of nasal cavity	0.005	0.995	0.000
Y84.2 Radiological procedure and radiotherapy	0.005	0.995	0.000
N03.8 Other	0.000	0.996	0.004
N03.7 Diffuse crescentic glomerulonephritis	0.000	0.996	0.004
N03.6 Dense deposit disease	0.000	0.996	0.004
N03.5 Diffuse mesangiocapillary glomerulonephritis	0.000	0.996	0.004
N03.4 Diffuse endocapillary proliferative glomerulonephritis	0.000	0.996	0.004
N03.3 Diffuse mesangial proliferative glomerulonephritis	0.000	0.996	0.004
N03.2 Diffuse membranous glomerulonephritis	0.000	0.996	0.004
N03.1 Focal and segmental glomerular lesions	0.000	0.996	0.004
N03.0 Minor glomerular abnormality	0.000	0.996	0.004
S01.3 Open wound of ear	0.000	0.996	0.004
L29 Pruritus	0.004	0.996	0.000
Z52.4 Kidney donor	0.004	0.996	0.000
K74.3 Primary biliary cirrhosis	0.000	0.996	0.004
S01.0 Open wound of scalp	0.000	0.996	0.004
S01.5 Open wound of lip and oral cavity	0.000	0.996	0.004
S01.2 Open wound of nose	0.000	0.996	0.004
G36.9 Acute disseminated demyelination, unspecified	0.000	0.996	0.004
G36.8 Other specified acute disseminated demyelination	0.000	0.996	0.004
G36.1 Acute and subacute haemorrhagic leukoencephalitis [Hurst]	0.000	0.996	0.004
G36.0 Neuromyelitis optica [Devic]	0.000	0.996	0.004
L29.2 Pruritus vulvae	0.004	0.996	0.000
D12.5 Sigmoid colon	0.004	0.996	0.000
S32.71 Multiple fractures of lumbar spine and pelvis (open)	0.000	0.996	0.004
T43.6 Psychostimulants with abuse potential	0.000	0.996	0.004
D50.8 Other iron deficiency anaemias	0.000	0.996	0.004
T43.2 Other and unspecified antidepressants	0.000	0.996	0.004
T43.9 Psychotropic drug, unspecified	0.000	0.996	0.003
T43.8 Other psychotropic drugs, not elsewhere classified	0.000	0.996	0.003
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.000	0.996	0.003
K63.5 Polyp of colon	0.004	0.996	0.000
S32 Fracture of lumbar spine and pelvis	0.000	0.996	0.004
Y84.0 Cardiac catheterisation	0.003	0.997	0.000
L29.3 Anogenital pruritus, unspecified	0.003	0.997	0.000
L29.1 Pruritus scroti	0.003	0.997	0.000
H61.2 Impacted cerumen	0.003	0.997	0.000
Y84 Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure	0.003	0.997	0.000
S32.4 Fracture of acetabulum	0.000	0.997	0.003
R93.2 Abnormal findings on diagnostic imaging of liver and biliary tract	0.000	0.997	0.003
S32.40 Fracture of acetabulum (closed)	0.000	0.997	0.003
S32.8 Fracture of other and unspecified parts of lumbar spine and pelvis	0.000	0.997	0.003
T43.3 Phenothiazine antipsychotics and neuroleptics	0.000	0.997	0.003
I84.3 External thrombosed haemorrhoids	0.000	0.997	0.003
S01.4 Open wound of cheek and temporomandibular area	0.000	0.997	0.003
Y84.4 Aspiration of fluid	0.003	0.997	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.000	0.997	0.003
Y84.6 Urinary catheterisation	0.003	0.997	0.000
L29.8 Other pruritus	0.003	0.997	0.000
S32.1 Fracture of sacrum	0.000	0.997	0.003
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.000	0.997	0.003
S32.80 Fracture of other and unspecified parts of lumbar spine and pelvis (closed)	0.000	0.997	0.003
K60.5 Anorectal fistula	0.000	0.997	0.003
T43.0 Tricyclic and tetracyclic antidepressants	0.000	0.997	0.003
D12.8 Rectum	0.003	0.997	0.000
H61 Other disorders of external ear	0.003	0.997	0.000
H61.1 Non-infective disorders of pinna	0.003	0.997	0.000
S32.2 Fracture of coccyx	0.000	0.997	0.003
F31.0 Bipolar affective disorder, current episode hypomanic	0.000	0.997	0.003
H60.0 Abscess of external ear	0.003	0.997	0.000
S32.5 Fracture of pubis	0.000	0.997	0.003
H60 Otitis externa	0.003	0.997	0.000
H60.8 Other otitis externa	0.003	0.997	0.000
H60.1 Cellulitis of external ear	0.003	0.997	0.000
K60 Fissure and fistula of anal and rectal regions	0.000	0.997	0.003
Y84.7 Blood-sampling	0.003	0.997	0.000
Y84.5 Insertion of gastric or duodenal sound	0.003	0.997	0.000
Y84.3 Shock therapy	0.003	0.997	0.000
S32.41 Fracture of acetabulum (open)	0.000	0.997	0.002
S32.0 Fracture of lumbar vertebra	0.000	0.997	0.003
S32.3 Fracture of ilium	0.000	0.997	0.002
R93.3 Abnormal findings on diagnostic imaging of other parts of digestive tract	0.000	0.997	0.003
X59.3 Sports and athletics area	0.003	0.997	0.000
S32.10 Fracture of sacrum (closed)	0.000	0.997	0.002
S32.81 Fracture of other and unspecified parts of lumbar spine and pelvis (open)	0.000	0.997	0.002
Y84.9 Medical procedure, unspecified	0.002	0.997	0.000
S42.0 Fracture of clavicle	0.000	0.998	0.002
I51.9 Heart disease, unspecified	0.002	0.998	0.000
H60.5 Acute otitis externa, non-infective	0.002	0.998	0.000
H60-H62 Diseases of external ear	0.002	0.998	0.000
O80.0 Spontaneous vertex delivery	0.000	0.998	0.002
S32.11 Fracture of sacrum (open)	0.000	0.998	0.002
H60.4 Cholesteatoma of external ear	0.002	0.998	0.000
H81 Disorders of vestibular function	0.002	0.998	0.000
Y84.1 Kidney dialysis	0.002	0.998	0.000
K60.4 Rectal fistula	0.000	0.998	0.002
S32.21 Fracture of coccyx (open)	0.000	0.998	0.002
S32.20 Fracture of coccyx (closed)	0.000	0.998	0.002
S32.51 Fracture of pubis (open)	0.000	0.998	0.002
H60.2 Malignant otitis externa	0.002	0.998	0.000
I24.8 Other forms of acute ischaemic heart disease	0.000	0.998	0.002
S32.50 Fracture of pubis (closed)	0.000	0.998	0.002
S82.00 Fracture of patella (closed)	0.002	0.998	0.000
H61.0 Perichondritis of external ear	0.002	0.998	0.000
Z52 Donors of organs and tissues	0.002	0.998	0.000
N50.1 Vascular disorders of male genital organs	0.000	0.998	0.002
S32.01 Fracture of lumbar vertebra (open)	0.000	0.998	0.002
T43.5 Other and unspecified antipsychotics and neuroleptics	0.000	0.998	0.002
F31 Bipolar affective disorder	0.000	0.998	0.002
S32.31 Fracture of ilium (open)	0.000	0.998	0.002
F31.1 Bipolar affective disorder, current episode manic without psychotic symptoms	0.000	0.998	0.002
H61.9 Disorder of external ear, unspecified	0.002	0.998	0.000
H61.3 Acquired stenosis of external ear canal	0.002	0.998	0.000
H81.3 Other peripheral vertigo	0.002	0.998	0.000
I89.1 Lymphangitis	0.002	0.998	0.000
Y84.8 Other medical procedures	0.002	0.998	0.000
Z52.3 Bone marrow donor	0.002	0.998	0.000
S42.01 Fracture of clavicle (open)	0.000	0.998	0.002
H62 Disorders of external ear in diseases classified elsewhere	0.002	0.998	0.000
F31.4 Bipolar affective disorder, current episode severe depression without psychotic symptoms	0.000	0.998	0.002
H60.3 Other infective otitis externa	0.002	0.998	0.000
H81.8 Other disorders of vestibular function	0.002	0.998	0.000
H81.4 Vertigo of central origin	0.002	0.998	0.000
F31.2 Bipolar affective disorder, current episode manic with psychotic symptoms	0.000	0.998	0.002
F31.5 Bipolar affective disorder, current episode severe depression with psychotic symptoms	0.000	0.998	0.002
H81.2 Vestibular neuronitis	0.002	0.998	0.000
S32.00 Fracture of lumbar vertebra (closed)	0.000	0.998	0.002
H81.9 Disorder of vestibular function, unspecified	0.002	0.998	0.000
K60.1 Chronic anal fissure	0.000	0.998	0.002
S32.30 Fracture of ilium (closed)	0.000	0.998	0.002
H61.8 Other specified disorders of external ear	0.002	0.998	0.000
D50.9 Iron deficiency anaemia, unspecified	0.000	0.998	0.002
M25.51 Pain in joint (Shoulder region)	0.000	0.998	0.002
F31.6 Bipolar affective disorder, current episode mixed	0.000	0.998	0.002
X59 Exposure to unspecified factor	0.002	0.998	0.000
M87.20 Osteonecrosis due to previous trauma (Multiple sites)	0.002	0.998	0.000
Z52.9 Donor of unspecified organ or tissue	0.002	0.998	0.000
Z52.7 Heart donor	0.002	0.998	0.000
Z52.6 Liver donor	0.002	0.998	0.000
Z52.5 Cornea donor	0.002	0.998	0.000
Z52.2 Bone donor	0.002	0.998	0.000
Z52.1 Skin donor	0.002	0.998	0.000
F31.8 Other bipolar affective disorders	0.000	0.998	0.002
I31.9 Disease of pericardium, unspecified	0.000	0.998	0.002
C61 Malignant neoplasm of prostate	0.002	0.998	0.000
H81.0 Meniere's disease	0.000	0.998	0.002
M65.43 Radial styloid tenosynovitis [de Quervain] (Forearm)	0.000	0.998	0.002
X59.2 School, other institution and public administrative area	0.002	0.998	0.000
Z52.8 Donor of other organs and tissues	0.002	0.998	0.000
G43.9 Migraine, unspecified	0.000	0.998	0.002
Z52.0 Blood donor	0.002	0.998	0.000
F31.7 Bipolar affective disorder, currently in remission	0.000	0.998	0.002
O80.9 Single spontaneous delivery, unspecified	0.000	0.998	0.002
K74 Fibrosis and cirrhosis of liver	0.000	0.998	0.002
S06.50 Traumatic subdural haemorrhage (without open intracranial wound)	0.002	0.998	0.000
K60.0 Acute anal fissure	0.000	0.998	0.002
H62.8 Other disorders of external ear in diseases classified elsewhere	0.001	0.998	0.000
H62.4 Otitis externa in other diseases classified elsewhere	0.001	0.998	0.000
H62.3 Otitis externa in other infectious and parasitic diseases classified elsewhere	0.001	0.998	0.000
H62.2 Otitis externa in mycoses	0.001	0.998	0.000
H62.1 Otitis externa in viral diseases classified elsewhere	0.001	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations